March 11 (Reuters) - A federal judge ruled in favor of Merck (MRK.N), opens new tab in litigation accusing it of concealing the risks of Gardasil, a vaccine to prevent cervical and other cancers ...

More than 200 lawsuits demand warnings on Gardasil labels about an autoimmune disease called Postural Orthostatic Tachycardia Syndrome, or POTS, and Primary Ovarian Insufficiency, or POI ...

This new plant will manufacture the HPV vaccines Gardasil and Gardasil 9, Merck told The News & Observer on Monday, while the site as a whole continues to produce vaccines against measles ...

STORY HIGHLIGHTS Merck opens new vaccine facility in Durham. New facility will manufacture HPV vaccines Gardasil and Gardasil 9. Merck plans to invest $8 billion more in U.S. by 2028. A global ...

In its rush to market its human papillomavirus vaccine, Merck forgot to make a strong and compelling case for compulsory immunization. Merck's human papillomavirus (HPV) vaccine Gardasil should ...

A federal judge in North Carolina on Tuesday granted an order for summary judgment in favor of Merck (NYSE:MRK) regarding lawsuits accusing the drugmaker of failing to warn consumers its Gardasil ...

The message was apparently designed to fit a broader push in China to boost male vaccination against HPV-related diseases following Gardasil’s local approval earlier this year in males aged 9 to 26.

A close-up of a person's hand holding a bottle of pharmaceuticals ... expecting a strong performance from Keytruda and Gardasil, a lack of major risks, and management’s efforts to extend ...